Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap

Por Locke, Frederick L., Anasetti, Claudio
Publicado no J Immunother Cancer (2017)

Off-the-shelf TCR for graft-versus-leukemia without GVHD

Por Locke, Frederick L., Anasetti, Claudio
Publicado no Blood (2018)

Beat pediatric ALL MRD: CD28 CAR T and transplant

Por Ruella, Marco, Locke, Frederick L.
Publicado no Blood (2019)

A Possible Cure for Refractory DLBCL: CARs Are Headed in the Right Direction

Por Chavez, Julio C., Locke, Frederick L.
Publicado no Mol Ther (2017)

CAR T cell therapy for B-cell lymphomas

Por Chavez, Julio C., Locke, Frederick L.
Publicado no Best Pract Res Clin Haematol (2018)

Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma: A Review

Por Locke, Frederick L., Go, William Y., Neelapu, Sattva S.
Publicado no JAMA Oncol (2020)

The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy

Por Kimmel, Gregory J., Locke, Frederick L., Altrock, Philipp M.
Publicado no Proc Biol Sci (2021)

Immunotherapy strategies for multiple myeloma: the present and the future

Por Locke, Frederick L, Nishihori, Taiga, Alsina, Melissa, Kharfan-Dabaja, Mohamed A
Publicado no Immunotherapy (2013)

Conditional deletion of PTEN in peripheral T cells augments TCR-mediated activation but does not abrogate CD28 dependency or prevent anergy induction

Por Locke, Frederick L., Zha, Yuan-yuan, Zheng, Yan, Driessens, Gregory, Gajewski, Thomas F.
Publicado em 2013

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma

Por Locke, Frederick L, Menges, Meghan, Veerapathran, Anandharaman, Coppola, Domenico, Gabrilovich, Dmitry, Anasetti, Claudio
Publicado no J Immunother Cancer (2015)

Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chro...

Por Chavez, Julio C., Kharfan-Dabaja, Mohamed A., Kim, Jongphil, Yue, Binglin, Dalia, Samir, Pinilla-Ibarz, Javier, Anasetti, Claudio, Locke, Frederick L.
Publicado no Leuk Res (2014)

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Por Maziarz, Richard T., Schuster, Stephen J., Romanov, Vadim V., Rusch, Elisha S., Li, Junlong, Signorovitch, James E., Maloney, David G., Locke, Frederick L.
Publicado no Blood Adv (2020)

Grading and management of cytokine release syndrome in patients treated with tisagenlecleucel in the JULIET trial

Por Schuster, Stephen J., Maziarz, Richard T., Rusch, Elisha S., Li, Junlong, Signorovitch, James E., Romanov, Vadim V., Locke, Frederick L., Maloney, David G.
Publicado no Blood Adv (2020)

Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients

Por Hampras, Shalaka S., Locke, Frederick L., Chavez, Julio C., Patel, Nishit S., Giuliano, Anna R., Miller, Kyle, Gheit, Tarik, Tommasino, Massimo, Rollison, Dana E.
Publicado no Leuk Lymphoma (2017)

Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells

Por Kharfan-Dabaja, Mohamed A., Jain, Michael D., Aulakh, Sonikpreet, Ayala, Ernesto, Zubair, Abba C., Tun, Han W., Liu, Hien D., Locke, Frederick L., Chavez, Julio C.
Publicado no Am J Hematol (2019)

Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center Experience

Por Kharfan-Dabaja, Mohamed A., Kumar, Ambuj, Stingo, Facundo E., Khimani, Farhad, Hussaini, Mohammad, Ayala, Ernesto, Nishihori, Taiga, Shah, Bijal, Locke, Frederick L., Pinilla-Ibarz, Javier, Chavez, Julio C.
Publicado no Clin Lymphoma Myeloma Leuk (2017)

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit ‘ALL’

Por Neelapu, Sattva S., Tummala, Sudhakar, Kebriaei, Partow, Wierda, William, Locke, Frederick L., Lin, Yi, Jain, Nitin, Daver, Naval, Gulbis, Alison M., Adkins, Sherry, Rezvani, Katayoun, Hwu, Patrick, Shpall, Elizabeth J.
Publicado no Nat Rev Clin Oncol (2018)

Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease

Por Frairia, Chiara, Nicolosi, Maura, Shapiro, Jamie, Kim, Jongphil, Betts, Brian C., Fernandez, Hugo F., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Jose Leonel, Perez, Lia, Pidala, Joseph, Anasetti, Claudio
Publicado no Biol Blood Marrow Transplant (2020)

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

Por Neelapu, Sattva S., Jacobson, Caron A., Oluwole, Olalekan O., Munoz, Javier, Deol, Abhinav, Miklos, David B., Bartlett, Nancy L., Braunschweig, Ira, Jiang, Yizhou, Kim, Jenny J., Zheng, Lianqing, Rossi, John M., Locke, Frederick L.
Publicado no Blood (2020)

Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results

Por Pidala, Joseph, Kim, Jongphil, Betts, Brian C., Alsina, Melissa, Ayala, Ernesto, Fernandez, Hugo F., Field, Teresa, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Mishra, Asmita, Nishihori, Taiga, Ochoa-Bayona, Leonel, Perez, Lia, Riches, Marcie, Anasetti, Claudio
Publicado no Biol Blood Marrow Transplant (2015)